EG434197 Inhibitors
Chemical inhibitors of EG434197 operate through various mechanisms to affect the function and activity of this protein. Alsterpaullone, a known inhibitor of cyclin-dependent kinases (CDKs), can modulate the phosphorylation state of EG434197, assuming it is regulated during the cell cycle. This inhibition would prevent the cellular machinery from executing processes that could activate EG434197. Similarly, PD98059 and U0126 target the MEK1/2 enzymes, leading to the suppression of the ERK pathway. Since the ERK pathway is integral to numerous cellular functions, the inhibition by these chemicals can prevent the activation of EG434197 if it is part of this signaling cascade.
LY294002 and Wortmannin are inhibitors that target the phosphoinositide 3-kinases (PI3K) pathway. The inhibition of PI3K can suppress downstream signaling, including the AKT pathway, which could be crucial for the functional regulation of EG434197. In the same vein, SP600125 and SB203580 can inhibit the JNK and p38 MAP kinase pathways, respectively. Inhibiting these kinases can disrupt the stress response and inflammatory signaling, and if EG434197 is involved in such pathways, its activity would be inhibited. Y-27632, which inhibits Rho-associated protein kinase (ROCK), can also impact EG434197 if its function is ROCK-dependent. Rapamycin, by inhibiting the mammalian target of rapamycin (mTOR), can affect EG434197 if it is involved in processes regulated by mTOR, such as growth and metabolism. Gö6976's inhibition of protein kinase C (PKC) can alter signaling pathways where EG434197 is a downstream effector. Lastly, PP2 can inhibit Src family tyrosine kinases, which, if involved in the regulation of EG434197, can lead to a reduction in its activity due to the prevention of tyrosine phosphorylation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a known inhibitor of cyclin-dependent kinases (CDKs), which are pivotal in the regulation of the cell cycle. Since EG434197 is a protein that may be regulated during cell cycle progression, inhibition of CDKs by Alsterpaullone could result in an altered phosphorylation state of EG434197, thus functionally inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of the mitogen-activated protein kinases 1 and 2 (MEK1/2), which leads to the suppression of the extracellular signal-regulated kinase (ERK) pathway. As ERK pathway is involved in multiple cellular processes including those that EG434197 might be part of, inhibition by PD98059 could prevent EG434197 from exerting its role within this signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K), which play a crucial role in the AKT signaling pathway that is involved in cell survival and proliferation. Inhibition of PI3K by LY294002 could reduce AKT activation, potentially inhibiting downstream proteins like EG434197 that may require PI3K/AKT pathway activity for their functional expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinases (JNK), which are part of the mitogen-activated protein kinase (MAPK) pathway important for cellular stress responses. By inhibiting JNK, SP600125 could functionally inhibit the activity of EG434197 if its activity is regulated as part of the cellular response to stress mediated by the JNK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a well-known inhibitor of p38 MAP kinase, which is involved in inflammatory responses and cell differentiation. The inhibition of p38 MAP kinase by SB203580 could result in the functional inhibition of EG434197 if it plays a role in pathways requiring p38 MAP kinase activity, such as response to cytokines or environmental stressors. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of the Rho-associated protein kinase (ROCK), which is implicated in processes like cell motility and apoptosis. If EG434197 is involved in signaling pathways or cellular functions that are dependent on ROCK activity, inhibition by Y-27632 would lead to a functional inhibition of EG434197 by preventing its required ROCK-mediated post-translational modifications. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another inhibitor of MEK1/2, similar to PD98059, and therefore inhibits the ERK pathway. Inhibition of MEK1/2 by U0126 can prevent the activation of downstream proteins that are regulated by ERK signaling, which could include EG434197 if it is functionally connected to this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor, like LY294002. It irreversibly inhibits PI3K, leading to the suppression of the AKT signaling pathway. By doing so, Wortmannin could functionally inhibit EG434197 if the protein's activity or stability is dependent on signals propagated through the PI3K/AKT pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR), a key regulator of cell growth and metabolism. Inhibiting mTOR by Rapamycin could lead to the functional inhibition of EG434197 if EG434197 is involved in mTOR signaling pathways, which control cellular processes like protein synthesis and autophagy. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a potent inhibitor of protein kinase C (PKC), which is involved in various cellular signaling pathways. Inhibition of PKC by Gö6976 could result in the functional inhibition of EG434197 if it is regulated by PKC-mediated phosphorylation or partakes in PKC-dependent signaling processes. | ||||||